Reaction
Conversion Disorder reporting signals
As of the last recalculation, Conversion Disorder appears in 1,909 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is SEVOFLURANE (PRR 21.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sevoflurane | 16 | 21.2 | 21.2 |
| Fexofenadine Hcl | 13 | 15.4 | 15.5 |
| Lurasidone Hydrochloride | 24 | 12.7 | 12.7 |
| Oxcarbazepine | 32 | 10.9 | 10.9 |
| Carbamazepine | 61 | 10.2 | 10.2 |
| Paliperidone | 21 | 9.9 | 9.9 |
| Divalproex Sodium | 40 | 9.6 | 9.6 |
| Propofol | 31 | 9.4 | 9.4 |
| Bupivacaine | 8 | 9.4 | 9.4 |
| Fentanyl Citrate | 14 | 8.6 | 8.6 |
| Rocuronium Bromide | 9 | 8.4 | 8.4 |
| Atomoxetine Hydrochloride | 17 | 7.8 | 7.9 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 6 | 7.6 | 7.6 |
| Modafinil | 22 | 7.5 | 7.5 |
| Fluoxetine | 43 | 7.2 | 7.2 |
| Esketamine Hydrochloride | 11 | 6.8 | 6.8 |
| Fexofenadine Hydrochloride | 13 | 6.6 | 6.6 |
| Asenapine Maleate | 5 | 6.3 | 6.3 |
| Oseltamivir Phosphate | 13 | 5.8 | 5.8 |
| Guanfacine | 4 | 5.6 | 5.6 |
| Clobazam | 12 | 5.4 | 5.4 |
| Varenicline Tartrate | 36 | 5.0 | 5.0 |
| Ethyl Alcohol | 10 | 4.0 | 4.0 |
| Eptinezumab-Jjmr | 3 | 3.6 | 3.6 |
| Glecaprevir And Pibrentasvir | 3 | 3.0 | 3.0 |
| Drospirenone And Ethinyl Estradiol | 12 | 3.0 | 3.0 |
| Fremanezumab-Vfrm | 3 | 2.9 | 2.9 |
| Buprenorphine | 19 | 2.3 | 2.3 |
| Orlistat | 5 | 2.1 | 2.1 |
| Galcanezumab-Gnlm | 4 | 1.4 | 1.4 |
| Nirmatrelvir And Ritonavir | 6 | 1.2 | 1.2 |